Global Nonalcoholic Steatohepatitis Diagnostic Market Growth (Status and Outlook) 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
The global Nonalcoholic Steatohepatitis Diagnostic market size is projected to grow from US$ 1392.5 million in 2022 to US$ 2025.4 million in 2029; it is expected to grow at a CAGR of 5.5% from 2023 to 2029.
United States market for Nonalcoholic Steatohepatitis Diagnostic is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Nonalcoholic Steatohepatitis Diagnostic is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Nonalcoholic Steatohepatitis Diagnostic is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Nonalcoholic Steatohepatitis Diagnostic players cover Echosens, Prometheus Laboratories, GENFIT SA, Siemens Medical Solutions USA, Inc., BioPredictive S.A.S, Quest Diagnostics Incorporated., Meridian Bioscience, Inc. and Laboratory Corporation of America Holdings, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
Nonalcoholic steatohepatitis (NASH) is liver inflammation and damage caused by a buildup of fat in the liver. It is part of a group of conditions called nonalcoholic fatty liver disease.
LPI (LP Information)' newest research report, the “Nonalcoholic Steatohepatitis Diagnostic Industry Forecast” looks at past sales and reviews total world Nonalcoholic Steatohepatitis Diagnostic sales in 2022, providing a comprehensive analysis by region and market sector of projected Nonalcoholic Steatohepatitis Diagnostic sales for 2023 through 2029. With Nonalcoholic Steatohepatitis Diagnostic sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Nonalcoholic Steatohepatitis Diagnostic industry.
This Insight Report provides a comprehensive analysis of the global Nonalcoholic Steatohepatitis Diagnostic landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Nonalcoholic Steatohepatitis Diagnostic portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Nonalcoholic Steatohepatitis Diagnostic market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Nonalcoholic Steatohepatitis Diagnostic and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Nonalcoholic Steatohepatitis Diagnostic.
This report presents a comprehensive overview, market shares, and growth opportunities of Nonalcoholic Steatohepatitis Diagnostic market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
The global Nonalcoholic Steatohepatitis Diagnostic market size is projected to grow from US$ 1392.5 million in 2022 to US$ 2025.4 million in 2029; it is expected to grow at a CAGR of 5.5% from 2023 to 2029.
United States market for Nonalcoholic Steatohepatitis Diagnostic is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Nonalcoholic Steatohepatitis Diagnostic is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Nonalcoholic Steatohepatitis Diagnostic is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Nonalcoholic Steatohepatitis Diagnostic players cover Echosens, Prometheus Laboratories, GENFIT SA, Siemens Medical Solutions USA, Inc., BioPredictive S.A.S, Quest Diagnostics Incorporated., Meridian Bioscience, Inc. and Laboratory Corporation of America Holdings, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
Nonalcoholic steatohepatitis (NASH) is liver inflammation and damage caused by a buildup of fat in the liver. It is part of a group of conditions called nonalcoholic fatty liver disease.
LPI (LP Information)' newest research report, the “Nonalcoholic Steatohepatitis Diagnostic Industry Forecast” looks at past sales and reviews total world Nonalcoholic Steatohepatitis Diagnostic sales in 2022, providing a comprehensive analysis by region and market sector of projected Nonalcoholic Steatohepatitis Diagnostic sales for 2023 through 2029. With Nonalcoholic Steatohepatitis Diagnostic sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Nonalcoholic Steatohepatitis Diagnostic industry.
This Insight Report provides a comprehensive analysis of the global Nonalcoholic Steatohepatitis Diagnostic landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Nonalcoholic Steatohepatitis Diagnostic portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Nonalcoholic Steatohepatitis Diagnostic market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Nonalcoholic Steatohepatitis Diagnostic and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Nonalcoholic Steatohepatitis Diagnostic.
This report presents a comprehensive overview, market shares, and growth opportunities of Nonalcoholic Steatohepatitis Diagnostic market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
- Serum Biomarkers
- Hepatic Fibrosis Biomarkers
- Oxidative Stress Biomarkers
- Apoptosis Biomarkers
- Others
- Pharma & CRO Industry
- Hospitals
- Academic Research Institutes
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Echosens
- Prometheus Laboratories
- GENFIT SA
- Siemens Medical Solutions USA, Inc.
- BioPredictive S.A.S
- Quest Diagnostics Incorporated.
- Meridian Bioscience, Inc.
- Laboratory Corporation of America Holdings
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Nonalcoholic Steatohepatitis Diagnostic Market Size 2018-2029
2.1.2 Nonalcoholic Steatohepatitis Diagnostic Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Nonalcoholic Steatohepatitis Diagnostic Segment by Type
2.2.1 Serum Biomarkers
2.2.2 Hepatic Fibrosis Biomarkers
2.2.3 Oxidative Stress Biomarkers
2.2.4 Apoptosis Biomarkers
2.2.5 Others
2.3 Nonalcoholic Steatohepatitis Diagnostic Market Size by Type
2.3.1 Nonalcoholic Steatohepatitis Diagnostic Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Nonalcoholic Steatohepatitis Diagnostic Market Size Market Share by Type (2018-2023)
2.4 Nonalcoholic Steatohepatitis Diagnostic Segment by Application
2.4.1 Pharma & CRO Industry
2.4.2 Hospitals
2.4.3 Academic Research Institutes
2.4.4 Others
2.5 Nonalcoholic Steatohepatitis Diagnostic Market Size by Application
2.5.1 Nonalcoholic Steatohepatitis Diagnostic Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Nonalcoholic Steatohepatitis Diagnostic Market Size Market Share by Application (2018-2023)
3 NONALCOHOLIC STEATOHEPATITIS DIAGNOSTIC MARKET SIZE BY PLAYER
3.1 Nonalcoholic Steatohepatitis Diagnostic Market Size Market Share by Players
3.1.1 Global Nonalcoholic Steatohepatitis Diagnostic Revenue by Players (2018-2023)
3.1.2 Global Nonalcoholic Steatohepatitis Diagnostic Revenue Market Share by Players (2018-2023)
3.2 Global Nonalcoholic Steatohepatitis Diagnostic Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 NONALCOHOLIC STEATOHEPATITIS DIAGNOSTIC BY REGIONS
4.1 Nonalcoholic Steatohepatitis Diagnostic Market Size by Regions (2018-2023)
4.2 Americas Nonalcoholic Steatohepatitis Diagnostic Market Size Growth (2018-2023)
4.3 APAC Nonalcoholic Steatohepatitis Diagnostic Market Size Growth (2018-2023)
4.4 Europe Nonalcoholic Steatohepatitis Diagnostic Market Size Growth (2018-2023)
4.5 Middle East & Africa Nonalcoholic Steatohepatitis Diagnostic Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas Nonalcoholic Steatohepatitis Diagnostic Market Size by Country (2018-2023)
5.2 Americas Nonalcoholic Steatohepatitis Diagnostic Market Size by Type (2018-2023)
5.3 Americas Nonalcoholic Steatohepatitis Diagnostic Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Nonalcoholic Steatohepatitis Diagnostic Market Size by Region (2018-2023)
6.2 APAC Nonalcoholic Steatohepatitis Diagnostic Market Size by Type (2018-2023)
6.3 APAC Nonalcoholic Steatohepatitis Diagnostic Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Nonalcoholic Steatohepatitis Diagnostic by Country (2018-2023)
7.2 Europe Nonalcoholic Steatohepatitis Diagnostic Market Size by Type (2018-2023)
7.3 Europe Nonalcoholic Steatohepatitis Diagnostic Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Nonalcoholic Steatohepatitis Diagnostic by Region (2018-2023)
8.2 Middle East & Africa Nonalcoholic Steatohepatitis Diagnostic Market Size by Type (2018-2023)
8.3 Middle East & Africa Nonalcoholic Steatohepatitis Diagnostic Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL NONALCOHOLIC STEATOHEPATITIS DIAGNOSTIC MARKET FORECAST
10.1 Global Nonalcoholic Steatohepatitis Diagnostic Forecast by Regions (2024-2029)
10.1.1 Global Nonalcoholic Steatohepatitis Diagnostic Forecast by Regions (2024-2029)
10.1.2 Americas Nonalcoholic Steatohepatitis Diagnostic Forecast
10.1.3 APAC Nonalcoholic Steatohepatitis Diagnostic Forecast
10.1.4 Europe Nonalcoholic Steatohepatitis Diagnostic Forecast
10.1.5 Middle East & Africa Nonalcoholic Steatohepatitis Diagnostic Forecast
10.2 Americas Nonalcoholic Steatohepatitis Diagnostic Forecast by Country (2024-2029)
10.2.1 United States Nonalcoholic Steatohepatitis Diagnostic Market Forecast
10.2.2 Canada Nonalcoholic Steatohepatitis Diagnostic Market Forecast
10.2.3 Mexico Nonalcoholic Steatohepatitis Diagnostic Market Forecast
10.2.4 Brazil Nonalcoholic Steatohepatitis Diagnostic Market Forecast
10.3 APAC Nonalcoholic Steatohepatitis Diagnostic Forecast by Region (2024-2029)
10.3.1 China Nonalcoholic Steatohepatitis Diagnostic Market Forecast
10.3.2 Japan Nonalcoholic Steatohepatitis Diagnostic Market Forecast
10.3.3 Korea Nonalcoholic Steatohepatitis Diagnostic Market Forecast
10.3.4 Southeast Asia Nonalcoholic Steatohepatitis Diagnostic Market Forecast
10.3.5 India Nonalcoholic Steatohepatitis Diagnostic Market Forecast
10.3.6 Australia Nonalcoholic Steatohepatitis Diagnostic Market Forecast
10.4 Europe Nonalcoholic Steatohepatitis Diagnostic Forecast by Country (2024-2029)
10.4.1 Germany Nonalcoholic Steatohepatitis Diagnostic Market Forecast
10.4.2 France Nonalcoholic Steatohepatitis Diagnostic Market Forecast
10.4.3 UK Nonalcoholic Steatohepatitis Diagnostic Market Forecast
10.4.4 Italy Nonalcoholic Steatohepatitis Diagnostic Market Forecast
10.4.5 Russia Nonalcoholic Steatohepatitis Diagnostic Market Forecast
10.5 Middle East & Africa Nonalcoholic Steatohepatitis Diagnostic Forecast by Region (2024-2029)
10.5.1 Egypt Nonalcoholic Steatohepatitis Diagnostic Market Forecast
10.5.2 South Africa Nonalcoholic Steatohepatitis Diagnostic Market Forecast
10.5.3 Israel Nonalcoholic Steatohepatitis Diagnostic Market Forecast
10.5.4 Turkey Nonalcoholic Steatohepatitis Diagnostic Market Forecast
10.5.5 GCC Countries Nonalcoholic Steatohepatitis Diagnostic Market Forecast
10.6 Global Nonalcoholic Steatohepatitis Diagnostic Forecast by Type (2024-2029)
10.7 Global Nonalcoholic Steatohepatitis Diagnostic Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 Echosens
11.1.1 Echosens Company Information
11.1.2 Echosens Nonalcoholic Steatohepatitis Diagnostic Product Offered
11.1.3 Echosens Nonalcoholic Steatohepatitis Diagnostic Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Echosens Main Business Overview
11.1.5 Echosens Latest Developments
11.2 Prometheus Laboratories
11.2.1 Prometheus Laboratories Company Information
11.2.2 Prometheus Laboratories Nonalcoholic Steatohepatitis Diagnostic Product Offered
11.2.3 Prometheus Laboratories Nonalcoholic Steatohepatitis Diagnostic Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Prometheus Laboratories Main Business Overview
11.2.5 Prometheus Laboratories Latest Developments
11.3 GENFIT SA
11.3.1 GENFIT SA Company Information
11.3.2 GENFIT SA Nonalcoholic Steatohepatitis Diagnostic Product Offered
11.3.3 GENFIT SA Nonalcoholic Steatohepatitis Diagnostic Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 GENFIT SA Main Business Overview
11.3.5 GENFIT SA Latest Developments
11.4 Siemens Medical Solutions USA, Inc.
11.4.1 Siemens Medical Solutions USA, Inc. Company Information
11.4.2 Siemens Medical Solutions USA, Inc. Nonalcoholic Steatohepatitis Diagnostic Product Offered
11.4.3 Siemens Medical Solutions USA, Inc. Nonalcoholic Steatohepatitis Diagnostic Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Siemens Medical Solutions USA, Inc. Main Business Overview
11.4.5 Siemens Medical Solutions USA, Inc. Latest Developments
11.5 BioPredictive S.A.S
11.5.1 BioPredictive S.A.S Company Information
11.5.2 BioPredictive S.A.S Nonalcoholic Steatohepatitis Diagnostic Product Offered
11.5.3 BioPredictive S.A.S Nonalcoholic Steatohepatitis Diagnostic Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 BioPredictive S.A.S Main Business Overview
11.5.5 BioPredictive S.A.S Latest Developments
11.6 Quest Diagnostics Incorporated.
11.6.1 Quest Diagnostics Incorporated. Company Information
11.6.2 Quest Diagnostics Incorporated. Nonalcoholic Steatohepatitis Diagnostic Product Offered
11.6.3 Quest Diagnostics Incorporated. Nonalcoholic Steatohepatitis Diagnostic Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 Quest Diagnostics Incorporated. Main Business Overview
11.6.5 Quest Diagnostics Incorporated. Latest Developments
11.7 Meridian Bioscience, Inc.
11.7.1 Meridian Bioscience, Inc. Company Information
11.7.2 Meridian Bioscience, Inc. Nonalcoholic Steatohepatitis Diagnostic Product Offered
11.7.3 Meridian Bioscience, Inc. Nonalcoholic Steatohepatitis Diagnostic Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 Meridian Bioscience, Inc. Main Business Overview
11.7.5 Meridian Bioscience, Inc. Latest Developments
11.8 Laboratory Corporation of America Holdings
11.8.1 Laboratory Corporation of America Holdings Company Information
11.8.2 Laboratory Corporation of America Holdings Nonalcoholic Steatohepatitis Diagnostic Product Offered
11.8.3 Laboratory Corporation of America Holdings Nonalcoholic Steatohepatitis Diagnostic Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 Laboratory Corporation of America Holdings Main Business Overview
11.8.5 Laboratory Corporation of America Holdings Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Nonalcoholic Steatohepatitis Diagnostic Market Size 2018-2029
2.1.2 Nonalcoholic Steatohepatitis Diagnostic Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Nonalcoholic Steatohepatitis Diagnostic Segment by Type
2.2.1 Serum Biomarkers
2.2.2 Hepatic Fibrosis Biomarkers
2.2.3 Oxidative Stress Biomarkers
2.2.4 Apoptosis Biomarkers
2.2.5 Others
2.3 Nonalcoholic Steatohepatitis Diagnostic Market Size by Type
2.3.1 Nonalcoholic Steatohepatitis Diagnostic Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Nonalcoholic Steatohepatitis Diagnostic Market Size Market Share by Type (2018-2023)
2.4 Nonalcoholic Steatohepatitis Diagnostic Segment by Application
2.4.1 Pharma & CRO Industry
2.4.2 Hospitals
2.4.3 Academic Research Institutes
2.4.4 Others
2.5 Nonalcoholic Steatohepatitis Diagnostic Market Size by Application
2.5.1 Nonalcoholic Steatohepatitis Diagnostic Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Nonalcoholic Steatohepatitis Diagnostic Market Size Market Share by Application (2018-2023)
3 NONALCOHOLIC STEATOHEPATITIS DIAGNOSTIC MARKET SIZE BY PLAYER
3.1 Nonalcoholic Steatohepatitis Diagnostic Market Size Market Share by Players
3.1.1 Global Nonalcoholic Steatohepatitis Diagnostic Revenue by Players (2018-2023)
3.1.2 Global Nonalcoholic Steatohepatitis Diagnostic Revenue Market Share by Players (2018-2023)
3.2 Global Nonalcoholic Steatohepatitis Diagnostic Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 NONALCOHOLIC STEATOHEPATITIS DIAGNOSTIC BY REGIONS
4.1 Nonalcoholic Steatohepatitis Diagnostic Market Size by Regions (2018-2023)
4.2 Americas Nonalcoholic Steatohepatitis Diagnostic Market Size Growth (2018-2023)
4.3 APAC Nonalcoholic Steatohepatitis Diagnostic Market Size Growth (2018-2023)
4.4 Europe Nonalcoholic Steatohepatitis Diagnostic Market Size Growth (2018-2023)
4.5 Middle East & Africa Nonalcoholic Steatohepatitis Diagnostic Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas Nonalcoholic Steatohepatitis Diagnostic Market Size by Country (2018-2023)
5.2 Americas Nonalcoholic Steatohepatitis Diagnostic Market Size by Type (2018-2023)
5.3 Americas Nonalcoholic Steatohepatitis Diagnostic Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Nonalcoholic Steatohepatitis Diagnostic Market Size by Region (2018-2023)
6.2 APAC Nonalcoholic Steatohepatitis Diagnostic Market Size by Type (2018-2023)
6.3 APAC Nonalcoholic Steatohepatitis Diagnostic Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Nonalcoholic Steatohepatitis Diagnostic by Country (2018-2023)
7.2 Europe Nonalcoholic Steatohepatitis Diagnostic Market Size by Type (2018-2023)
7.3 Europe Nonalcoholic Steatohepatitis Diagnostic Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Nonalcoholic Steatohepatitis Diagnostic by Region (2018-2023)
8.2 Middle East & Africa Nonalcoholic Steatohepatitis Diagnostic Market Size by Type (2018-2023)
8.3 Middle East & Africa Nonalcoholic Steatohepatitis Diagnostic Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL NONALCOHOLIC STEATOHEPATITIS DIAGNOSTIC MARKET FORECAST
10.1 Global Nonalcoholic Steatohepatitis Diagnostic Forecast by Regions (2024-2029)
10.1.1 Global Nonalcoholic Steatohepatitis Diagnostic Forecast by Regions (2024-2029)
10.1.2 Americas Nonalcoholic Steatohepatitis Diagnostic Forecast
10.1.3 APAC Nonalcoholic Steatohepatitis Diagnostic Forecast
10.1.4 Europe Nonalcoholic Steatohepatitis Diagnostic Forecast
10.1.5 Middle East & Africa Nonalcoholic Steatohepatitis Diagnostic Forecast
10.2 Americas Nonalcoholic Steatohepatitis Diagnostic Forecast by Country (2024-2029)
10.2.1 United States Nonalcoholic Steatohepatitis Diagnostic Market Forecast
10.2.2 Canada Nonalcoholic Steatohepatitis Diagnostic Market Forecast
10.2.3 Mexico Nonalcoholic Steatohepatitis Diagnostic Market Forecast
10.2.4 Brazil Nonalcoholic Steatohepatitis Diagnostic Market Forecast
10.3 APAC Nonalcoholic Steatohepatitis Diagnostic Forecast by Region (2024-2029)
10.3.1 China Nonalcoholic Steatohepatitis Diagnostic Market Forecast
10.3.2 Japan Nonalcoholic Steatohepatitis Diagnostic Market Forecast
10.3.3 Korea Nonalcoholic Steatohepatitis Diagnostic Market Forecast
10.3.4 Southeast Asia Nonalcoholic Steatohepatitis Diagnostic Market Forecast
10.3.5 India Nonalcoholic Steatohepatitis Diagnostic Market Forecast
10.3.6 Australia Nonalcoholic Steatohepatitis Diagnostic Market Forecast
10.4 Europe Nonalcoholic Steatohepatitis Diagnostic Forecast by Country (2024-2029)
10.4.1 Germany Nonalcoholic Steatohepatitis Diagnostic Market Forecast
10.4.2 France Nonalcoholic Steatohepatitis Diagnostic Market Forecast
10.4.3 UK Nonalcoholic Steatohepatitis Diagnostic Market Forecast
10.4.4 Italy Nonalcoholic Steatohepatitis Diagnostic Market Forecast
10.4.5 Russia Nonalcoholic Steatohepatitis Diagnostic Market Forecast
10.5 Middle East & Africa Nonalcoholic Steatohepatitis Diagnostic Forecast by Region (2024-2029)
10.5.1 Egypt Nonalcoholic Steatohepatitis Diagnostic Market Forecast
10.5.2 South Africa Nonalcoholic Steatohepatitis Diagnostic Market Forecast
10.5.3 Israel Nonalcoholic Steatohepatitis Diagnostic Market Forecast
10.5.4 Turkey Nonalcoholic Steatohepatitis Diagnostic Market Forecast
10.5.5 GCC Countries Nonalcoholic Steatohepatitis Diagnostic Market Forecast
10.6 Global Nonalcoholic Steatohepatitis Diagnostic Forecast by Type (2024-2029)
10.7 Global Nonalcoholic Steatohepatitis Diagnostic Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 Echosens
11.1.1 Echosens Company Information
11.1.2 Echosens Nonalcoholic Steatohepatitis Diagnostic Product Offered
11.1.3 Echosens Nonalcoholic Steatohepatitis Diagnostic Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Echosens Main Business Overview
11.1.5 Echosens Latest Developments
11.2 Prometheus Laboratories
11.2.1 Prometheus Laboratories Company Information
11.2.2 Prometheus Laboratories Nonalcoholic Steatohepatitis Diagnostic Product Offered
11.2.3 Prometheus Laboratories Nonalcoholic Steatohepatitis Diagnostic Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Prometheus Laboratories Main Business Overview
11.2.5 Prometheus Laboratories Latest Developments
11.3 GENFIT SA
11.3.1 GENFIT SA Company Information
11.3.2 GENFIT SA Nonalcoholic Steatohepatitis Diagnostic Product Offered
11.3.3 GENFIT SA Nonalcoholic Steatohepatitis Diagnostic Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 GENFIT SA Main Business Overview
11.3.5 GENFIT SA Latest Developments
11.4 Siemens Medical Solutions USA, Inc.
11.4.1 Siemens Medical Solutions USA, Inc. Company Information
11.4.2 Siemens Medical Solutions USA, Inc. Nonalcoholic Steatohepatitis Diagnostic Product Offered
11.4.3 Siemens Medical Solutions USA, Inc. Nonalcoholic Steatohepatitis Diagnostic Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Siemens Medical Solutions USA, Inc. Main Business Overview
11.4.5 Siemens Medical Solutions USA, Inc. Latest Developments
11.5 BioPredictive S.A.S
11.5.1 BioPredictive S.A.S Company Information
11.5.2 BioPredictive S.A.S Nonalcoholic Steatohepatitis Diagnostic Product Offered
11.5.3 BioPredictive S.A.S Nonalcoholic Steatohepatitis Diagnostic Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 BioPredictive S.A.S Main Business Overview
11.5.5 BioPredictive S.A.S Latest Developments
11.6 Quest Diagnostics Incorporated.
11.6.1 Quest Diagnostics Incorporated. Company Information
11.6.2 Quest Diagnostics Incorporated. Nonalcoholic Steatohepatitis Diagnostic Product Offered
11.6.3 Quest Diagnostics Incorporated. Nonalcoholic Steatohepatitis Diagnostic Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 Quest Diagnostics Incorporated. Main Business Overview
11.6.5 Quest Diagnostics Incorporated. Latest Developments
11.7 Meridian Bioscience, Inc.
11.7.1 Meridian Bioscience, Inc. Company Information
11.7.2 Meridian Bioscience, Inc. Nonalcoholic Steatohepatitis Diagnostic Product Offered
11.7.3 Meridian Bioscience, Inc. Nonalcoholic Steatohepatitis Diagnostic Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 Meridian Bioscience, Inc. Main Business Overview
11.7.5 Meridian Bioscience, Inc. Latest Developments
11.8 Laboratory Corporation of America Holdings
11.8.1 Laboratory Corporation of America Holdings Company Information
11.8.2 Laboratory Corporation of America Holdings Nonalcoholic Steatohepatitis Diagnostic Product Offered
11.8.3 Laboratory Corporation of America Holdings Nonalcoholic Steatohepatitis Diagnostic Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 Laboratory Corporation of America Holdings Main Business Overview
11.8.5 Laboratory Corporation of America Holdings Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Nonalcoholic Steatohepatitis Diagnostic Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Serum Biomarkers
Table 3. Major Players of Hepatic Fibrosis Biomarkers
Table 4. Major Players of Oxidative Stress Biomarkers
Table 5. Major Players of Apoptosis Biomarkers
Table 6. Major Players of Others
Table 7. Nonalcoholic Steatohepatitis Diagnostic Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 8. Global Nonalcoholic Steatohepatitis Diagnostic Market Size by Type (2018-2023) & ($ Millions)
Table 9. Global Nonalcoholic Steatohepatitis Diagnostic Market Size Market Share by Type (2018-2023)
Table 10. Nonalcoholic Steatohepatitis Diagnostic Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 11. Global Nonalcoholic Steatohepatitis Diagnostic Market Size by Application (2018-2023) & ($ Millions)
Table 12. Global Nonalcoholic Steatohepatitis Diagnostic Market Size Market Share by Application (2018-2023)
Table 13. Global Nonalcoholic Steatohepatitis Diagnostic Revenue by Players (2018-2023) & ($ Millions)
Table 14. Global Nonalcoholic Steatohepatitis Diagnostic Revenue Market Share by Player (2018-2023)
Table 15. Nonalcoholic Steatohepatitis Diagnostic Key Players Head office and Products Offered
Table 16. Nonalcoholic Steatohepatitis Diagnostic Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global Nonalcoholic Steatohepatitis Diagnostic Market Size by Regions 2018-2023 & ($ Millions)
Table 20. Global Nonalcoholic Steatohepatitis Diagnostic Market Size Market Share by Regions (2018-2023)
Table 21. Global Nonalcoholic Steatohepatitis Diagnostic Revenue by Country/Region (2018-2023) & ($ millions)
Table 22. Global Nonalcoholic Steatohepatitis Diagnostic Revenue Market Share by Country/Region (2018-2023)
Table 23. Americas Nonalcoholic Steatohepatitis Diagnostic Market Size by Country (2018-2023) & ($ Millions)
Table 24. Americas Nonalcoholic Steatohepatitis Diagnostic Market Size Market Share by Country (2018-2023)
Table 25. Americas Nonalcoholic Steatohepatitis Diagnostic Market Size by Type (2018-2023) & ($ Millions)
Table 26. Americas Nonalcoholic Steatohepatitis Diagnostic Market Size Market Share by Type (2018-2023)
Table 27. Americas Nonalcoholic Steatohepatitis Diagnostic Market Size by Application (2018-2023) & ($ Millions)
Table 28. Americas Nonalcoholic Steatohepatitis Diagnostic Market Size Market Share by Application (2018-2023)
Table 29. APAC Nonalcoholic Steatohepatitis Diagnostic Market Size by Region (2018-2023) & ($ Millions)
Table 30. APAC Nonalcoholic Steatohepatitis Diagnostic Market Size Market Share by Region (2018-2023)
Table 31. APAC Nonalcoholic Steatohepatitis Diagnostic Market Size by Type (2018-2023) & ($ Millions)
Table 32. APAC Nonalcoholic Steatohepatitis Diagnostic Market Size Market Share by Type (2018-2023)
Table 33. APAC Nonalcoholic Steatohepatitis Diagnostic Market Size by Application (2018-2023) & ($ Millions)
Table 34. APAC Nonalcoholic Steatohepatitis Diagnostic Market Size Market Share by Application (2018-2023)
Table 35. Europe Nonalcoholic Steatohepatitis Diagnostic Market Size by Country (2018-2023) & ($ Millions)
Table 36. Europe Nonalcoholic Steatohepatitis Diagnostic Market Size Market Share by Country (2018-2023)
Table 37. Europe Nonalcoholic Steatohepatitis Diagnostic Market Size by Type (2018-2023) & ($ Millions)
Table 38. Europe Nonalcoholic Steatohepatitis Diagnostic Market Size Market Share by Type (2018-2023)
Table 39. Europe Nonalcoholic Steatohepatitis Diagnostic Market Size by Application (2018-2023) & ($ Millions)
Table 40. Europe Nonalcoholic Steatohepatitis Diagnostic Market Size Market Share by Application (2018-2023)
Table 41. Middle East & Africa Nonalcoholic Steatohepatitis Diagnostic Market Size by Region (2018-2023) & ($ Millions)
Table 42. Middle East & Africa Nonalcoholic Steatohepatitis Diagnostic Market Size Market Share by Region (2018-2023)
Table 43. Middle East & Africa Nonalcoholic Steatohepatitis Diagnostic Market Size by Type (2018-2023) & ($ Millions)
Table 44. Middle East & Africa Nonalcoholic Steatohepatitis Diagnostic Market Size Market Share by Type (2018-2023)
Table 45. Middle East & Africa Nonalcoholic Steatohepatitis Diagnostic Market Size by Application (2018-2023) & ($ Millions)
Table 46. Middle East & Africa Nonalcoholic Steatohepatitis Diagnostic Market Size Market Share by Application (2018-2023)
Table 47. Key Market Drivers & Growth Opportunities of Nonalcoholic Steatohepatitis Diagnostic
Table 48. Key Market Challenges & Risks of Nonalcoholic Steatohepatitis Diagnostic
Table 49. Key Industry Trends of Nonalcoholic Steatohepatitis Diagnostic
Table 50. Global Nonalcoholic Steatohepatitis Diagnostic Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 51. Global Nonalcoholic Steatohepatitis Diagnostic Market Size Market Share Forecast by Regions (2024-2029)
Table 52. Global Nonalcoholic Steatohepatitis Diagnostic Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 53. Global Nonalcoholic Steatohepatitis Diagnostic Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 54. Echosens Details, Company Type, Nonalcoholic Steatohepatitis Diagnostic Area Served and Its Competitors
Table 55. Echosens Nonalcoholic Steatohepatitis Diagnostic Product Offered
Table 56. Echosens Nonalcoholic Steatohepatitis Diagnostic Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 57. Echosens Main Business
Table 58. Echosens Latest Developments
Table 59. Prometheus Laboratories Details, Company Type, Nonalcoholic Steatohepatitis Diagnostic Area Served and Its Competitors
Table 60. Prometheus Laboratories Nonalcoholic Steatohepatitis Diagnostic Product Offered
Table 61. Prometheus Laboratories Main Business
Table 62. Prometheus Laboratories Nonalcoholic Steatohepatitis Diagnostic Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 63. Prometheus Laboratories Latest Developments
Table 64. GENFIT SA Details, Company Type, Nonalcoholic Steatohepatitis Diagnostic Area Served and Its Competitors
Table 65. GENFIT SA Nonalcoholic Steatohepatitis Diagnostic Product Offered
Table 66. GENFIT SA Main Business
Table 67. GENFIT SA Nonalcoholic Steatohepatitis Diagnostic Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 68. GENFIT SA Latest Developments
Table 69. Siemens Medical Solutions USA, Inc. Details, Company Type, Nonalcoholic Steatohepatitis Diagnostic Area Served and Its Competitors
Table 70. Siemens Medical Solutions USA, Inc. Nonalcoholic Steatohepatitis Diagnostic Product Offered
Table 71. Siemens Medical Solutions USA, Inc. Main Business
Table 72. Siemens Medical Solutions USA, Inc. Nonalcoholic Steatohepatitis Diagnostic Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 73. Siemens Medical Solutions USA, Inc. Latest Developments
Table 74. BioPredictive S.A.S Details, Company Type, Nonalcoholic Steatohepatitis Diagnostic Area Served and Its Competitors
Table 75. BioPredictive S.A.S Nonalcoholic Steatohepatitis Diagnostic Product Offered
Table 76. BioPredictive S.A.S Main Business
Table 77. BioPredictive S.A.S Nonalcoholic Steatohepatitis Diagnostic Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 78. BioPredictive S.A.S Latest Developments
Table 79. Quest Diagnostics Incorporated. Details, Company Type, Nonalcoholic Steatohepatitis Diagnostic Area Served and Its Competitors
Table 80. Quest Diagnostics Incorporated. Nonalcoholic Steatohepatitis Diagnostic Product Offered
Table 81. Quest Diagnostics Incorporated. Main Business
Table 82. Quest Diagnostics Incorporated. Nonalcoholic Steatohepatitis Diagnostic Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 83. Quest Diagnostics Incorporated. Latest Developments
Table 84. Meridian Bioscience, Inc. Details, Company Type, Nonalcoholic Steatohepatitis Diagnostic Area Served and Its Competitors
Table 85. Meridian Bioscience, Inc. Nonalcoholic Steatohepatitis Diagnostic Product Offered
Table 86. Meridian Bioscience, Inc. Main Business
Table 87. Meridian Bioscience, Inc. Nonalcoholic Steatohepatitis Diagnostic Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 88. Meridian Bioscience, Inc. Latest Developments
Table 89. Laboratory Corporation of America Holdings Details, Company Type, Nonalcoholic Steatohepatitis Diagnostic Area Served and Its Competitors
Table 90. Laboratory Corporation of America Holdings Nonalcoholic Steatohepatitis Diagnostic Product Offered
Table 91. Laboratory Corporation of America Holdings Main Business
Table 92. Laboratory Corporation of America Holdings Nonalcoholic Steatohepatitis Diagnostic Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 93. Laboratory Corporation of America Holdings Latest Developments
Table 1. Nonalcoholic Steatohepatitis Diagnostic Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Serum Biomarkers
Table 3. Major Players of Hepatic Fibrosis Biomarkers
Table 4. Major Players of Oxidative Stress Biomarkers
Table 5. Major Players of Apoptosis Biomarkers
Table 6. Major Players of Others
Table 7. Nonalcoholic Steatohepatitis Diagnostic Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 8. Global Nonalcoholic Steatohepatitis Diagnostic Market Size by Type (2018-2023) & ($ Millions)
Table 9. Global Nonalcoholic Steatohepatitis Diagnostic Market Size Market Share by Type (2018-2023)
Table 10. Nonalcoholic Steatohepatitis Diagnostic Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 11. Global Nonalcoholic Steatohepatitis Diagnostic Market Size by Application (2018-2023) & ($ Millions)
Table 12. Global Nonalcoholic Steatohepatitis Diagnostic Market Size Market Share by Application (2018-2023)
Table 13. Global Nonalcoholic Steatohepatitis Diagnostic Revenue by Players (2018-2023) & ($ Millions)
Table 14. Global Nonalcoholic Steatohepatitis Diagnostic Revenue Market Share by Player (2018-2023)
Table 15. Nonalcoholic Steatohepatitis Diagnostic Key Players Head office and Products Offered
Table 16. Nonalcoholic Steatohepatitis Diagnostic Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global Nonalcoholic Steatohepatitis Diagnostic Market Size by Regions 2018-2023 & ($ Millions)
Table 20. Global Nonalcoholic Steatohepatitis Diagnostic Market Size Market Share by Regions (2018-2023)
Table 21. Global Nonalcoholic Steatohepatitis Diagnostic Revenue by Country/Region (2018-2023) & ($ millions)
Table 22. Global Nonalcoholic Steatohepatitis Diagnostic Revenue Market Share by Country/Region (2018-2023)
Table 23. Americas Nonalcoholic Steatohepatitis Diagnostic Market Size by Country (2018-2023) & ($ Millions)
Table 24. Americas Nonalcoholic Steatohepatitis Diagnostic Market Size Market Share by Country (2018-2023)
Table 25. Americas Nonalcoholic Steatohepatitis Diagnostic Market Size by Type (2018-2023) & ($ Millions)
Table 26. Americas Nonalcoholic Steatohepatitis Diagnostic Market Size Market Share by Type (2018-2023)
Table 27. Americas Nonalcoholic Steatohepatitis Diagnostic Market Size by Application (2018-2023) & ($ Millions)
Table 28. Americas Nonalcoholic Steatohepatitis Diagnostic Market Size Market Share by Application (2018-2023)
Table 29. APAC Nonalcoholic Steatohepatitis Diagnostic Market Size by Region (2018-2023) & ($ Millions)
Table 30. APAC Nonalcoholic Steatohepatitis Diagnostic Market Size Market Share by Region (2018-2023)
Table 31. APAC Nonalcoholic Steatohepatitis Diagnostic Market Size by Type (2018-2023) & ($ Millions)
Table 32. APAC Nonalcoholic Steatohepatitis Diagnostic Market Size Market Share by Type (2018-2023)
Table 33. APAC Nonalcoholic Steatohepatitis Diagnostic Market Size by Application (2018-2023) & ($ Millions)
Table 34. APAC Nonalcoholic Steatohepatitis Diagnostic Market Size Market Share by Application (2018-2023)
Table 35. Europe Nonalcoholic Steatohepatitis Diagnostic Market Size by Country (2018-2023) & ($ Millions)
Table 36. Europe Nonalcoholic Steatohepatitis Diagnostic Market Size Market Share by Country (2018-2023)
Table 37. Europe Nonalcoholic Steatohepatitis Diagnostic Market Size by Type (2018-2023) & ($ Millions)
Table 38. Europe Nonalcoholic Steatohepatitis Diagnostic Market Size Market Share by Type (2018-2023)
Table 39. Europe Nonalcoholic Steatohepatitis Diagnostic Market Size by Application (2018-2023) & ($ Millions)
Table 40. Europe Nonalcoholic Steatohepatitis Diagnostic Market Size Market Share by Application (2018-2023)
Table 41. Middle East & Africa Nonalcoholic Steatohepatitis Diagnostic Market Size by Region (2018-2023) & ($ Millions)
Table 42. Middle East & Africa Nonalcoholic Steatohepatitis Diagnostic Market Size Market Share by Region (2018-2023)
Table 43. Middle East & Africa Nonalcoholic Steatohepatitis Diagnostic Market Size by Type (2018-2023) & ($ Millions)
Table 44. Middle East & Africa Nonalcoholic Steatohepatitis Diagnostic Market Size Market Share by Type (2018-2023)
Table 45. Middle East & Africa Nonalcoholic Steatohepatitis Diagnostic Market Size by Application (2018-2023) & ($ Millions)
Table 46. Middle East & Africa Nonalcoholic Steatohepatitis Diagnostic Market Size Market Share by Application (2018-2023)
Table 47. Key Market Drivers & Growth Opportunities of Nonalcoholic Steatohepatitis Diagnostic
Table 48. Key Market Challenges & Risks of Nonalcoholic Steatohepatitis Diagnostic
Table 49. Key Industry Trends of Nonalcoholic Steatohepatitis Diagnostic
Table 50. Global Nonalcoholic Steatohepatitis Diagnostic Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 51. Global Nonalcoholic Steatohepatitis Diagnostic Market Size Market Share Forecast by Regions (2024-2029)
Table 52. Global Nonalcoholic Steatohepatitis Diagnostic Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 53. Global Nonalcoholic Steatohepatitis Diagnostic Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 54. Echosens Details, Company Type, Nonalcoholic Steatohepatitis Diagnostic Area Served and Its Competitors
Table 55. Echosens Nonalcoholic Steatohepatitis Diagnostic Product Offered
Table 56. Echosens Nonalcoholic Steatohepatitis Diagnostic Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 57. Echosens Main Business
Table 58. Echosens Latest Developments
Table 59. Prometheus Laboratories Details, Company Type, Nonalcoholic Steatohepatitis Diagnostic Area Served and Its Competitors
Table 60. Prometheus Laboratories Nonalcoholic Steatohepatitis Diagnostic Product Offered
Table 61. Prometheus Laboratories Main Business
Table 62. Prometheus Laboratories Nonalcoholic Steatohepatitis Diagnostic Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 63. Prometheus Laboratories Latest Developments
Table 64. GENFIT SA Details, Company Type, Nonalcoholic Steatohepatitis Diagnostic Area Served and Its Competitors
Table 65. GENFIT SA Nonalcoholic Steatohepatitis Diagnostic Product Offered
Table 66. GENFIT SA Main Business
Table 67. GENFIT SA Nonalcoholic Steatohepatitis Diagnostic Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 68. GENFIT SA Latest Developments
Table 69. Siemens Medical Solutions USA, Inc. Details, Company Type, Nonalcoholic Steatohepatitis Diagnostic Area Served and Its Competitors
Table 70. Siemens Medical Solutions USA, Inc. Nonalcoholic Steatohepatitis Diagnostic Product Offered
Table 71. Siemens Medical Solutions USA, Inc. Main Business
Table 72. Siemens Medical Solutions USA, Inc. Nonalcoholic Steatohepatitis Diagnostic Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 73. Siemens Medical Solutions USA, Inc. Latest Developments
Table 74. BioPredictive S.A.S Details, Company Type, Nonalcoholic Steatohepatitis Diagnostic Area Served and Its Competitors
Table 75. BioPredictive S.A.S Nonalcoholic Steatohepatitis Diagnostic Product Offered
Table 76. BioPredictive S.A.S Main Business
Table 77. BioPredictive S.A.S Nonalcoholic Steatohepatitis Diagnostic Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 78. BioPredictive S.A.S Latest Developments
Table 79. Quest Diagnostics Incorporated. Details, Company Type, Nonalcoholic Steatohepatitis Diagnostic Area Served and Its Competitors
Table 80. Quest Diagnostics Incorporated. Nonalcoholic Steatohepatitis Diagnostic Product Offered
Table 81. Quest Diagnostics Incorporated. Main Business
Table 82. Quest Diagnostics Incorporated. Nonalcoholic Steatohepatitis Diagnostic Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 83. Quest Diagnostics Incorporated. Latest Developments
Table 84. Meridian Bioscience, Inc. Details, Company Type, Nonalcoholic Steatohepatitis Diagnostic Area Served and Its Competitors
Table 85. Meridian Bioscience, Inc. Nonalcoholic Steatohepatitis Diagnostic Product Offered
Table 86. Meridian Bioscience, Inc. Main Business
Table 87. Meridian Bioscience, Inc. Nonalcoholic Steatohepatitis Diagnostic Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 88. Meridian Bioscience, Inc. Latest Developments
Table 89. Laboratory Corporation of America Holdings Details, Company Type, Nonalcoholic Steatohepatitis Diagnostic Area Served and Its Competitors
Table 90. Laboratory Corporation of America Holdings Nonalcoholic Steatohepatitis Diagnostic Product Offered
Table 91. Laboratory Corporation of America Holdings Main Business
Table 92. Laboratory Corporation of America Holdings Nonalcoholic Steatohepatitis Diagnostic Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 93. Laboratory Corporation of America Holdings Latest Developments
LIST OF FIGURES
Figure 1. Nonalcoholic Steatohepatitis Diagnostic Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Nonalcoholic Steatohepatitis Diagnostic Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Nonalcoholic Steatohepatitis Diagnostic Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Nonalcoholic Steatohepatitis Diagnostic Sales Market Share by Country/Region (2022)
Figure 8. Nonalcoholic Steatohepatitis Diagnostic Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Nonalcoholic Steatohepatitis Diagnostic Market Size Market Share by Type in 2022
Figure 10. Nonalcoholic Steatohepatitis Diagnostic in Pharma & CRO Industry
Figure 11. Global Nonalcoholic Steatohepatitis Diagnostic Market: Pharma & CRO Industry (2018-2023) & ($ Millions)
Figure 12. Nonalcoholic Steatohepatitis Diagnostic in Hospitals
Figure 13. Global Nonalcoholic Steatohepatitis Diagnostic Market: Hospitals (2018-2023) & ($ Millions)
Figure 14. Nonalcoholic Steatohepatitis Diagnostic in Academic Research Institutes
Figure 15. Global Nonalcoholic Steatohepatitis Diagnostic Market: Academic Research Institutes (2018-2023) & ($ Millions)
Figure 16. Nonalcoholic Steatohepatitis Diagnostic in Others
Figure 17. Global Nonalcoholic Steatohepatitis Diagnostic Market: Others (2018-2023) & ($ Millions)
Figure 18. Global Nonalcoholic Steatohepatitis Diagnostic Market Size Market Share by Application in 2022
Figure 19. Global Nonalcoholic Steatohepatitis Diagnostic Revenue Market Share by Player in 2022
Figure 20. Global Nonalcoholic Steatohepatitis Diagnostic Market Size Market Share by Regions (2018-2023)
Figure 21. Americas Nonalcoholic Steatohepatitis Diagnostic Market Size 2018-2023 ($ Millions)
Figure 22. APAC Nonalcoholic Steatohepatitis Diagnostic Market Size 2018-2023 ($ Millions)
Figure 23. Europe Nonalcoholic Steatohepatitis Diagnostic Market Size 2018-2023 ($ Millions)
Figure 24. Middle East & Africa Nonalcoholic Steatohepatitis Diagnostic Market Size 2018-2023 ($ Millions)
Figure 25. Americas Nonalcoholic Steatohepatitis Diagnostic Value Market Share by Country in 2022
Figure 26. United States Nonalcoholic Steatohepatitis Diagnostic Market Size Growth 2018-2023 ($ Millions)
Figure 27. Canada Nonalcoholic Steatohepatitis Diagnostic Market Size Growth 2018-2023 ($ Millions)
Figure 28. Mexico Nonalcoholic Steatohepatitis Diagnostic Market Size Growth 2018-2023 ($ Millions)
Figure 29. Brazil Nonalcoholic Steatohepatitis Diagnostic Market Size Growth 2018-2023 ($ Millions)
Figure 30. APAC Nonalcoholic Steatohepatitis Diagnostic Market Size Market Share by Region in 2022
Figure 31. APAC Nonalcoholic Steatohepatitis Diagnostic Market Size Market Share by Type in 2022
Figure 32. APAC Nonalcoholic Steatohepatitis Diagnostic Market Size Market Share by Application in 2022
Figure 33. China Nonalcoholic Steatohepatitis Diagnostic Market Size Growth 2018-2023 ($ Millions)
Figure 34. Japan Nonalcoholic Steatohepatitis Diagnostic Market Size Growth 2018-2023 ($ Millions)
Figure 35. Korea Nonalcoholic Steatohepatitis Diagnostic Market Size Growth 2018-2023 ($ Millions)
Figure 36. Southeast Asia Nonalcoholic Steatohepatitis Diagnostic Market Size Growth 2018-2023 ($ Millions)
Figure 37. India Nonalcoholic Steatohepatitis Diagnostic Market Size Growth 2018-2023 ($ Millions)
Figure 38. Australia Nonalcoholic Steatohepatitis Diagnostic Market Size Growth 2018-2023 ($ Millions)
Figure 39. Europe Nonalcoholic Steatohepatitis Diagnostic Market Size Market Share by Country in 2022
Figure 40. Europe Nonalcoholic Steatohepatitis Diagnostic Market Size Market Share by Type (2018-2023)
Figure 41. Europe Nonalcoholic Steatohepatitis Diagnostic Market Size Market Share by Application (2018-2023)
Figure 42. Germany Nonalcoholic Steatohepatitis Diagnostic Market Size Growth 2018-2023 ($ Millions)
Figure 43. France Nonalcoholic Steatohepatitis Diagnostic Market Size Growth 2018-2023 ($ Millions)
Figure 44. UK Nonalcoholic Steatohepatitis Diagnostic Market Size Growth 2018-2023 ($ Millions)
Figure 45. Italy Nonalcoholic Steatohepatitis Diagnostic Market Size Growth 2018-2023 ($ Millions)
Figure 46. Russia Nonalcoholic Steatohepatitis Diagnostic Market Size Growth 2018-2023 ($ Millions)
Figure 47. Middle East & Africa Nonalcoholic Steatohepatitis Diagnostic Market Size Market Share by Region (2018-2023)
Figure 48. Middle East & Africa Nonalcoholic Steatohepatitis Diagnostic Market Size Market Share by Type (2018-2023)
Figure 49. Middle East & Africa Nonalcoholic Steatohepatitis Diagnostic Market Size Market Share by Application (2018-2023)
Figure 50. Egypt Nonalcoholic Steatohepatitis Diagnostic Market Size Growth 2018-2023 ($ Millions)
Figure 51. South Africa Nonalcoholic Steatohepatitis Diagnostic Market Size Growth 2018-2023 ($ Millions)
Figure 52. Israel Nonalcoholic Steatohepatitis Diagnostic Market Size Growth 2018-2023 ($ Millions)
Figure 53. Turkey Nonalcoholic Steatohepatitis Diagnostic Market Size Growth 2018-2023 ($ Millions)
Figure 54. GCC Country Nonalcoholic Steatohepatitis Diagnostic Market Size Growth 2018-2023 ($ Millions)
Figure 55. Americas Nonalcoholic Steatohepatitis Diagnostic Market Size 2024-2029 ($ Millions)
Figure 56. APAC Nonalcoholic Steatohepatitis Diagnostic Market Size 2024-2029 ($ Millions)
Figure 57. Europe Nonalcoholic Steatohepatitis Diagnostic Market Size 2024-2029 ($ Millions)
Figure 58. Middle East & Africa Nonalcoholic Steatohepatitis Diagnostic Market Size 2024-2029 ($ Millions)
Figure 59. United States Nonalcoholic Steatohepatitis Diagnostic Market Size 2024-2029 ($ Millions)
Figure 60. Canada Nonalcoholic Steatohepatitis Diagnostic Market Size 2024-2029 ($ Millions)
Figure 61. Mexico Nonalcoholic Steatohepatitis Diagnostic Market Size 2024-2029 ($ Millions)
Figure 62. Brazil Nonalcoholic Steatohepatitis Diagnostic Market Size 2024-2029 ($ Millions)
Figure 63. China Nonalcoholic Steatohepatitis Diagnostic Market Size 2024-2029 ($ Millions)
Figure 64. Japan Nonalcoholic Steatohepatitis Diagnostic Market Size 2024-2029 ($ Millions)
Figure 65. Korea Nonalcoholic Steatohepatitis Diagnostic Market Size 2024-2029 ($ Millions)
Figure 66. Southeast Asia Nonalcoholic Steatohepatitis Diagnostic Market Size 2024-2029 ($ Millions)
Figure 67. India Nonalcoholic Steatohepatitis Diagnostic Market Size 2024-2029 ($ Millions)
Figure 68. Australia Nonalcoholic Steatohepatitis Diagnostic Market Size 2024-2029 ($ Millions)
Figure 69. Germany Nonalcoholic Steatohepatitis Diagnostic Market Size 2024-2029 ($ Millions)
Figure 70. France Nonalcoholic Steatohepatitis Diagnostic Market Size 2024-2029 ($ Millions)
Figure 71. UK Nonalcoholic Steatohepatitis Diagnostic Market Size 2024-2029 ($ Millions)
Figure 72. Italy Nonalcoholic Steatohepatitis Diagnostic Market Size 2024-2029 ($ Millions)
Figure 73. Russia Nonalcoholic Steatohepatitis Diagnostic Market Size 2024-2029 ($ Millions)
Figure 74. Spain Nonalcoholic Steatohepatitis Diagnostic Market Size 2024-2029 ($ Millions)
Figure 75. Egypt Nonalcoholic Steatohepatitis Diagnostic Market Size 2024-2029 ($ Millions)
Figure 76. South Africa Nonalcoholic Steatohepatitis Diagnostic Market Size 2024-2029 ($ Millions)
Figure 77. Israel Nonalcoholic Steatohepatitis Diagnostic Market Size 2024-2029 ($ Millions)
Figure 78. Turkey Nonalcoholic Steatohepatitis Diagnostic Market Size 2024-2029 ($ Millions)
Figure 79. GCC Countries Nonalcoholic Steatohepatitis Diagnostic Market Size 2024-2029 ($ Millions)
Figure 80. Global Nonalcoholic Steatohepatitis Diagnostic Market Size Market Share Forecast by Type (2024-2029)
Figure 81. Global Nonalcoholic Steatohepatitis Diagnostic Market Size Market Share Forecast by Application (2024-2029)
Figure 1. Nonalcoholic Steatohepatitis Diagnostic Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Nonalcoholic Steatohepatitis Diagnostic Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Nonalcoholic Steatohepatitis Diagnostic Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Nonalcoholic Steatohepatitis Diagnostic Sales Market Share by Country/Region (2022)
Figure 8. Nonalcoholic Steatohepatitis Diagnostic Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Nonalcoholic Steatohepatitis Diagnostic Market Size Market Share by Type in 2022
Figure 10. Nonalcoholic Steatohepatitis Diagnostic in Pharma & CRO Industry
Figure 11. Global Nonalcoholic Steatohepatitis Diagnostic Market: Pharma & CRO Industry (2018-2023) & ($ Millions)
Figure 12. Nonalcoholic Steatohepatitis Diagnostic in Hospitals
Figure 13. Global Nonalcoholic Steatohepatitis Diagnostic Market: Hospitals (2018-2023) & ($ Millions)
Figure 14. Nonalcoholic Steatohepatitis Diagnostic in Academic Research Institutes
Figure 15. Global Nonalcoholic Steatohepatitis Diagnostic Market: Academic Research Institutes (2018-2023) & ($ Millions)
Figure 16. Nonalcoholic Steatohepatitis Diagnostic in Others
Figure 17. Global Nonalcoholic Steatohepatitis Diagnostic Market: Others (2018-2023) & ($ Millions)
Figure 18. Global Nonalcoholic Steatohepatitis Diagnostic Market Size Market Share by Application in 2022
Figure 19. Global Nonalcoholic Steatohepatitis Diagnostic Revenue Market Share by Player in 2022
Figure 20. Global Nonalcoholic Steatohepatitis Diagnostic Market Size Market Share by Regions (2018-2023)
Figure 21. Americas Nonalcoholic Steatohepatitis Diagnostic Market Size 2018-2023 ($ Millions)
Figure 22. APAC Nonalcoholic Steatohepatitis Diagnostic Market Size 2018-2023 ($ Millions)
Figure 23. Europe Nonalcoholic Steatohepatitis Diagnostic Market Size 2018-2023 ($ Millions)
Figure 24. Middle East & Africa Nonalcoholic Steatohepatitis Diagnostic Market Size 2018-2023 ($ Millions)
Figure 25. Americas Nonalcoholic Steatohepatitis Diagnostic Value Market Share by Country in 2022
Figure 26. United States Nonalcoholic Steatohepatitis Diagnostic Market Size Growth 2018-2023 ($ Millions)
Figure 27. Canada Nonalcoholic Steatohepatitis Diagnostic Market Size Growth 2018-2023 ($ Millions)
Figure 28. Mexico Nonalcoholic Steatohepatitis Diagnostic Market Size Growth 2018-2023 ($ Millions)
Figure 29. Brazil Nonalcoholic Steatohepatitis Diagnostic Market Size Growth 2018-2023 ($ Millions)
Figure 30. APAC Nonalcoholic Steatohepatitis Diagnostic Market Size Market Share by Region in 2022
Figure 31. APAC Nonalcoholic Steatohepatitis Diagnostic Market Size Market Share by Type in 2022
Figure 32. APAC Nonalcoholic Steatohepatitis Diagnostic Market Size Market Share by Application in 2022
Figure 33. China Nonalcoholic Steatohepatitis Diagnostic Market Size Growth 2018-2023 ($ Millions)
Figure 34. Japan Nonalcoholic Steatohepatitis Diagnostic Market Size Growth 2018-2023 ($ Millions)
Figure 35. Korea Nonalcoholic Steatohepatitis Diagnostic Market Size Growth 2018-2023 ($ Millions)
Figure 36. Southeast Asia Nonalcoholic Steatohepatitis Diagnostic Market Size Growth 2018-2023 ($ Millions)
Figure 37. India Nonalcoholic Steatohepatitis Diagnostic Market Size Growth 2018-2023 ($ Millions)
Figure 38. Australia Nonalcoholic Steatohepatitis Diagnostic Market Size Growth 2018-2023 ($ Millions)
Figure 39. Europe Nonalcoholic Steatohepatitis Diagnostic Market Size Market Share by Country in 2022
Figure 40. Europe Nonalcoholic Steatohepatitis Diagnostic Market Size Market Share by Type (2018-2023)
Figure 41. Europe Nonalcoholic Steatohepatitis Diagnostic Market Size Market Share by Application (2018-2023)
Figure 42. Germany Nonalcoholic Steatohepatitis Diagnostic Market Size Growth 2018-2023 ($ Millions)
Figure 43. France Nonalcoholic Steatohepatitis Diagnostic Market Size Growth 2018-2023 ($ Millions)
Figure 44. UK Nonalcoholic Steatohepatitis Diagnostic Market Size Growth 2018-2023 ($ Millions)
Figure 45. Italy Nonalcoholic Steatohepatitis Diagnostic Market Size Growth 2018-2023 ($ Millions)
Figure 46. Russia Nonalcoholic Steatohepatitis Diagnostic Market Size Growth 2018-2023 ($ Millions)
Figure 47. Middle East & Africa Nonalcoholic Steatohepatitis Diagnostic Market Size Market Share by Region (2018-2023)
Figure 48. Middle East & Africa Nonalcoholic Steatohepatitis Diagnostic Market Size Market Share by Type (2018-2023)
Figure 49. Middle East & Africa Nonalcoholic Steatohepatitis Diagnostic Market Size Market Share by Application (2018-2023)
Figure 50. Egypt Nonalcoholic Steatohepatitis Diagnostic Market Size Growth 2018-2023 ($ Millions)
Figure 51. South Africa Nonalcoholic Steatohepatitis Diagnostic Market Size Growth 2018-2023 ($ Millions)
Figure 52. Israel Nonalcoholic Steatohepatitis Diagnostic Market Size Growth 2018-2023 ($ Millions)
Figure 53. Turkey Nonalcoholic Steatohepatitis Diagnostic Market Size Growth 2018-2023 ($ Millions)
Figure 54. GCC Country Nonalcoholic Steatohepatitis Diagnostic Market Size Growth 2018-2023 ($ Millions)
Figure 55. Americas Nonalcoholic Steatohepatitis Diagnostic Market Size 2024-2029 ($ Millions)
Figure 56. APAC Nonalcoholic Steatohepatitis Diagnostic Market Size 2024-2029 ($ Millions)
Figure 57. Europe Nonalcoholic Steatohepatitis Diagnostic Market Size 2024-2029 ($ Millions)
Figure 58. Middle East & Africa Nonalcoholic Steatohepatitis Diagnostic Market Size 2024-2029 ($ Millions)
Figure 59. United States Nonalcoholic Steatohepatitis Diagnostic Market Size 2024-2029 ($ Millions)
Figure 60. Canada Nonalcoholic Steatohepatitis Diagnostic Market Size 2024-2029 ($ Millions)
Figure 61. Mexico Nonalcoholic Steatohepatitis Diagnostic Market Size 2024-2029 ($ Millions)
Figure 62. Brazil Nonalcoholic Steatohepatitis Diagnostic Market Size 2024-2029 ($ Millions)
Figure 63. China Nonalcoholic Steatohepatitis Diagnostic Market Size 2024-2029 ($ Millions)
Figure 64. Japan Nonalcoholic Steatohepatitis Diagnostic Market Size 2024-2029 ($ Millions)
Figure 65. Korea Nonalcoholic Steatohepatitis Diagnostic Market Size 2024-2029 ($ Millions)
Figure 66. Southeast Asia Nonalcoholic Steatohepatitis Diagnostic Market Size 2024-2029 ($ Millions)
Figure 67. India Nonalcoholic Steatohepatitis Diagnostic Market Size 2024-2029 ($ Millions)
Figure 68. Australia Nonalcoholic Steatohepatitis Diagnostic Market Size 2024-2029 ($ Millions)
Figure 69. Germany Nonalcoholic Steatohepatitis Diagnostic Market Size 2024-2029 ($ Millions)
Figure 70. France Nonalcoholic Steatohepatitis Diagnostic Market Size 2024-2029 ($ Millions)
Figure 71. UK Nonalcoholic Steatohepatitis Diagnostic Market Size 2024-2029 ($ Millions)
Figure 72. Italy Nonalcoholic Steatohepatitis Diagnostic Market Size 2024-2029 ($ Millions)
Figure 73. Russia Nonalcoholic Steatohepatitis Diagnostic Market Size 2024-2029 ($ Millions)
Figure 74. Spain Nonalcoholic Steatohepatitis Diagnostic Market Size 2024-2029 ($ Millions)
Figure 75. Egypt Nonalcoholic Steatohepatitis Diagnostic Market Size 2024-2029 ($ Millions)
Figure 76. South Africa Nonalcoholic Steatohepatitis Diagnostic Market Size 2024-2029 ($ Millions)
Figure 77. Israel Nonalcoholic Steatohepatitis Diagnostic Market Size 2024-2029 ($ Millions)
Figure 78. Turkey Nonalcoholic Steatohepatitis Diagnostic Market Size 2024-2029 ($ Millions)
Figure 79. GCC Countries Nonalcoholic Steatohepatitis Diagnostic Market Size 2024-2029 ($ Millions)
Figure 80. Global Nonalcoholic Steatohepatitis Diagnostic Market Size Market Share Forecast by Type (2024-2029)
Figure 81. Global Nonalcoholic Steatohepatitis Diagnostic Market Size Market Share Forecast by Application (2024-2029)
